Choi Grace R, Porter Co-Burn J, Ackerman Michael J
Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905-0001, USA.
Pediatr Clin North Am. 2004 Oct;51(5):1289-303. doi: 10.1016/j.pcl.2004.04.015.
This article focuses on implantable cardioverter-defibrillator (ICD) therapy in the child/adolescent who is predisposed to sudden cardiac death because of an underlying channelopathy. As such, the primary channelopathies are reviewed briefly. Next, the history of the ICD device and the technological advancements that have enabled its use in pediatrics are discussed. Finally, the clinical experience with ICDs in the young is summarized and general indications for device therapy in young patients who have a channelopathy are provided.
本文聚焦于因潜在通道病而易发生心源性猝死的儿童/青少年的植入式心脏复律除颤器(ICD)治疗。因此,将简要回顾主要的通道病。接下来,将讨论ICD设备的历史以及使其能够应用于儿科的技术进步。最后,总结了ICD在年轻人中的临床经验,并提供了针对患有通道病的年轻患者进行设备治疗的一般指征。